Loading clinical trials...
Loading clinical trials...
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gérond'if
NCT07306949 · Transthyretin-type Cardiac Amyloidosis
NCT06096675 · Cardiac Amyloidosis
NCT06894290 · Cardiac Amyloidosis
NCT05797857 · Amyloid Cardiomyopathy, Transthyretin Cardiac Amyloidosis
NCT05760287 · Cardiac Amyloidosis
Geriatric Department, Broca Hospital
Paris, IIe-de-France
CHU Nantes
Nantes, Loire-Atlantique
CHU Poitiers
Poitiers, New Aquitaine
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions